SCHEMBL22280693

SCHEMBL22280693

CC(C)(C)c1ccc2c(c1)c1ccc(O)cc1c1nccn21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORA P35398 2/20 0.35
RORC P51449 2/20 0.35
RORB Q92753 2/20 0.35
LMNA P02545 2/20 0.35
TYR P14679 1/20 0.35
PGR P06401 1/20 0.34
CCNE1 P24864 3/20 0.33
CDK2 P24941 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TNKS O95271 1/20 0.32
HTR1D P28221 1/20 0.32
CCNE2 O96020 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
TACR1 P25103 2/20 0.31
KMT2A Q03164 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22262070 0.92 LMNA (0.35) RORARORCRORBLMNATYR
SCHEMBL841041 0.86 HTR1D (0.35) RORARORCRORBLMNAPGR
SCHEMBL12756766 0.83 PGR (0.45) RORARORCRORBPGRTNKS
SCHEMBL22280692 0.83 FGFR2 (0.36) RORARORCRORBPGRALDH1A1
SCHEMBL22281106 0.82 CASR (0.40) RORARORCRORBLMNAPGR
SCHEMBL22349169 0.80 CCNE1 (0.37) LMNACCNE1CDK2ALDH1A1CCNE2
SCHEMBL20561490 0.80 IKBKB (0.35) LMNACCNE1CDK2ALDH1A1CCNE2
SCHEMBL12076941 0.79 MAPT (0.41) LMNACCNE1CDK2ALDH1A1CCNE2
SCHEMBL22281105 0.78 PGR (0.37) RORARORCRORBPGRALDH1A1
SCHEMBL22262081 0.78 ESR1 (0.39) LMNACCNE1CDK2ALDH1A1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES EML4, TYR, TYMP RORA 2698/4885RORC 1441/4885RORB 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.